Great analysis @d_l_b - seems game is setup. Hope you are wrong and it opens gap up at 60c++ on US results announcement and allows all LT die heart fan to exit and book handsome profit.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%